相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Tenofovir monotherapy versus tenofovir and entecavir combination therapy in patients with entecavir-resistant chronic hepatitis B with multiple drug failure: results of a randomised trial
Young-Suk Lim et al.
GUT (2016)
Impact of nucleos(t)ide analogues on the estimated glomerular filtration rate in patients with chronic hepatitis B: a prospective cohort study in China
X. Qi et al.
JOURNAL OF VIRAL HEPATITIS (2015)
Antiviral Therapy for Chronic Hepatitis B Virus Infection and Development of Hepatocellular Carcinoma in a US Population
Stuart C. Gordon et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Mortality, Liver Transplantation, and Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B Treated With Entecavir vs Lamivudine
Young-Suk Lim et al.
GASTROENTEROLOGY (2014)
Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B-A Nationwide Cohort Study
Chun-Ying Wu et al.
GASTROENTEROLOGY (2014)
Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B
Scott Fung et al.
GASTROENTEROLOGY (2014)
No Detectable Resistance to Tenofovir Disoproxil Fumarate After 6 Years of Therapy in Patients With Chronic Hepatitis B
Kathryn M. Kitrinos et al.
HEPATOLOGY (2014)
Long-term efficacy and safety of emtricitabine plus tenofovir DF vs. tenofovir DF monotherapy in adefovir-experienced chronic hepatitis B patients
Thomas Berg et al.
JOURNAL OF HEPATOLOGY (2014)
LONG-TERM TREATMENT WITH TENOFOVIR IN TREATMENT-NAIVE OR -EXPERIENCED CHB PATIENTS IS EFFECTIVE AND WELL TOLERATED IN REAL-LIFE PRACTICE: 3 YEARS RESULTS OF THE VIREAL STUDY
G. -P. Pageaux et al.
JOURNAL OF HEPATOLOGY (2014)
Randomized Trial of the Virologic Response during up to Two Years of Entecavir-Adefovir Combination Therapy in Multiple-Drug-Refractory Chronic Hepatitis B Virus Patients
Young-Suk Lim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Entecavir Treatment Reduces Hepatic Events and Deaths in Chronic Hepatitis B Patients With Liver Cirrhosis
Grace Lai-Hung Wong et al.
HEPATOLOGY (2013)
Long-Term Entecavir Treatment Reduces Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection
Tetsuya Hosaka et al.
HEPATOLOGY (2013)
Randomized Trial of Entecavir plus Adefovir in Patients with Lamivudine-Resistant Chronic Hepatitis B Who Show Suboptimal Response to Lamivudine plus Adefovir
Young-Suk Lim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Entecavir plus adefovir combination treatment for chronic hepatitis B patients after failure of nucleoside/nucleotide analogues
Young-Suk Lim et al.
ANTIVIRAL THERAPY (2012)
Efficacy of Entecavir With or Without Tenofovir Disoproxil Fumarate for Nucleos(t)ide-Naive Patients With Chronic Hepatitis B
Anna S. Lok et al.
GASTROENTEROLOGY (2012)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2012)
Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: An international multicenter cohort study
Jorg Petersen et al.
JOURNAL OF HEPATOLOGY (2012)
Management of treatment failure in chronic hepatitis B
Fabien Zoulim et al.
JOURNAL OF HEPATOLOGY (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Selection of chronic hepatitis B therapy with high barrier to resistance
Robert Gish et al.
LANCET INFECTIOUS DISEASES (2012)
KASL Clinical Practice Guidelines: Management of chronic hepatitis B
CLINICAL AND MOLECULAR HEPATOLOGY (2012)
Comparison of multiplex restriction fragment mass polymorphism and sequencing analyses for detecting entecavir resistance in chronic hepatitis B
Kyung Ho Han et al.
ANTIVIRAL THERAPY (2011)
Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B
S. J. Patterson et al.
GUT (2011)
Tenofovir Is Effective Alone or With Emtricitabine in Adefovir-Treated Patients With Chronic-Hepatitis B Virus Infection
Thomas Berg et al.
GASTROENTEROLOGY (2010)
Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues
Florian van Boemmel et al.
HEPATOLOGY (2010)
Entecavir Treatment for up to 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir
Nae-Yun Heo et al.
JOURNAL OF HEPATOLOGY (2010)
Risk assessment for the development of hepatocellular carcinoma: According to on-treatment viral response during long-term lamivudine therapy in hepatitis B virus-related liver disease
Jong Ryul Eun et al.
JOURNAL OF HEPATOLOGY (2010)
Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
Fabien Zoulim et al.
GASTROENTEROLOGY (2009)
Efficacy of Entecavir in Patients with Chronic Hepatitis B Resistant to Both Lamivudine and Adefovir or to Lamivudine Alone
Ju Hyun Shim et al.
HEPATOLOGY (2009)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound
Nadia Warner et al.
HEPATOLOGY (2008)
Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure
Stephanie Villet et al.
JOURNAL OF HEPATOLOGY (2008)
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Patrick Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient
Stephanie Villet et al.
GASTROENTEROLOGY (2006)
Evolution of multi-drug resistant hepatitis B virus during sequential therapy
Hyung Joon Yim et al.
HEPATOLOGY (2006)
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2006)
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
TT Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
UH Iloeje et al.
GASTROENTEROLOGY (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine
GV Papatheodoridis et al.
HEPATOLOGY (2005)
Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir
MN Brunelle et al.
HEPATOLOGY (2005)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase
P Angus et al.
GASTROENTEROLOGY (2003)
Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient
JP Villeneuve et al.
JOURNAL OF HEPATOLOGY (2003)